rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    CMMB
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Chemomab Therapeutics and Scipher Medicine Announce SEC Registration Statement on Form S-4 Is Effective
      Nov 2Yahoo FinanceCMMB
      Chemomab Refines Share Structure in Domestication Deal Ahead of Scipher Merger

      Detailed price information for Chemomab Therapeutics Ltd ADR (CMMB-Q) from The Globe and Mail including charting and trades.

      Oct 1The Globe and MailCMMB
      12 Health Care Stocks Moving In Monday's After-Market Session - Silexion Therapeutics (NASDAQ:SLXN), Chem

      Gainers Silexion Therapeutics (NASDAQ:SLXN) shares rose 27.1% to $0.31 during Monday's after-market session. The market value of their outstanding shares is at $1.4 million. Chemomab Therapeutics (NASDAQ:CMMB)

      Sep 28BenzingaACTUCMMBSLXN
      Chemomab at H.C. Wainwright conference: merger sets ra push
      Sep 11Investing.comCMMB
      Chemomab Therapeutics to Present at H.C. Wainwright 28th Annual Global Investor Conference
      Aug 31Yahoo FinanceCMMB

      This is the newest page. Registered accounts read further back.